[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$lctx
Lineage Cell Therapeutics' OpRegen treatment shows promise with positive Phase X data, advancing towards Phase X trials. The company is also seeing increased support for its 'off-the-shelf' cell therapy solutions.
About $lctx
$LCTX is a cryptocurrency project focused on cell therapy treatments.
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX +46%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +110%
1-Year High: XXXXXXX on 2025-03-10
1-Year Low: XX on 2025-01-28
Engagements by network (24h): X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XXXX%
X Month: XXX +205%
X Months: XXXXX +213%
X Year: XXXXX +684%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-01-27
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $lctx in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XXXX%
X Month: XXX +212%
X Months: XXX +364%
X Year: XXXXX +675%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-10-26
The most influential creators that mention $lctx in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @LineageCell | X | XXXXX | X | XX |
| @StockTickerZone | X | XXXXX | X | XX |
| @barton70357 | X | XX | X | XX |
| @Dylanas19087 | X | X | X | XX |
| @AliciaEmbr76455 | X | XX | X | XX |
| @Skwld69988 | X | X | X | XX |
| @RahulGandi86155 | X | XX | X | X |
| @Trader_House05 | X | XX | X | X |
| @Molly_Keble | X | XX | X | X |
| @Stock_Marketr20 | XX | XXX | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-16
1-Year Low: X% on 2025-12-09
Most Supportive Themes:
- OpRegen Cell Therapy: (60%) Lineage Cell Therapeutics is advancing its OpRegen treatment for retinal diseases, showing positive Phase X data and moving towards Phase X trials.
- Off-the-Shelf Solutions: (30%) There is rising support for 'off-the-shelf' cell therapy solutions, particularly in non-oncology indications.
Most Critical Themes:
Top $lctx Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$LC $LCTX ⚠👀 Guys Don't miss the next move in a few hours 💸➡"
X Link @Gender49610 2025-12-12T06:24Z XX followers, XX engagements
"$LCTX D. Boral Capital Maintains Lineage Cell Therapeutics (LCTX) Buy Recommendation - Nasdaq #stocks #news"
X Link @StockTickerZone 2025-12-12T04:22Z 3973 followers, XX engagements
"@LineageCell Jill did a remarkable job she clearly an assist to $LCTX and articulated the company business smooth and easy to understand the companys major projects"
X Link @ablidy 2025-12-10T18:01Z XXX followers, XX engagements
"Wed like to thank Max Brennan for interviewing $LCTX s CFO Jill Howe on The BioHub Podcast. In the episode Jill shares how Lineages allogeneic cell therapy platform is advancing programs in dry AMD spinal cord injury hearing loss and type X diabetes. Listen on Apple Podcasts: Watch on YouTube: #CFOLeadership #FinanceFunction #ReplaceAndRestore"
X Link @LineageCell 2025-12-10T16:18Z 2348 followers, XXX engagements